Ambrx Biopharma Cayman, Inc.

Report date
9/30/2023
Quarter
2023 Q3
Filed
11/9/2023
Shares
5,574
Value ($000)
64
Weight
0.0%
2022 Q2 - 2023 Q3 (5 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).